KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 568.48M
Enterprise Value 324.86M
Trailing P/E N/A
Forward P/E 1-3.33
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)8.60
Price/Book (mrq)0.83
Enterprise Value/Revenue 33.12
Enterprise Value/EBITDA 6-0.75

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-84.03%
S&P500 52-Week Change 321.38%
52 Week High 34.3500
52 Week Low 30.5800
50-Day Moving Average 30.9307
200-Day Moving Average 31.1791

Share Statistics

Avg Vol (3 month) 3411.84k
Avg Vol (10 day) 31.2M
Shares Outstanding 5116.61M
Float 91.27M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jan. 30, 2020) 4761.91k
Short Ratio (Jan. 30, 2020) 43.48
Short % of Float (Jan. 30, 2020) 4N/A
Short % of Shares Outstanding (Jan. 30, 2020) 40.82%
Shares Short (prior month Dec. 30, 2019) 4273.82k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3May 23, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-426.31%

Management Effectiveness

Return on Assets (ttm)-37.48%
Return on Equity (ttm)-71.94%

Income Statement

Revenue (ttm)7.96M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)297.36k
EBITDA -33.32M
Net Income Avi to Common (ttm)-35.77M
Diluted EPS (ttm)-0.3950
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.82M
Total Cash Per Share (mrq)0.42
Total Debt (mrq)3.83M
Total Debt/Equity (mrq)4.64
Current Ratio (mrq)6.60
Book Value Per Share (mrq)0.72

Cash Flow Statement

Operating Cash Flow (ttm)-25.73M
Levered Free Cash Flow (ttm)-15.08M